|
Post by Anonymous on Nov 18, 2015 19:02:14 GMT
On my watch, the biggest penny stock winner of 2015 has been Novavax Inc. (Nasdaq: NVAX). We first recommended the stock back in November 2014 when shares were near $5. Since then, NVAX has climbed up and down. It's no longer a penny stock after the gains we've seen, but the stock still has plenty of upside.
Novavax is a biopharmaceutical company that develops vaccines for pandemic flu viruses, rabies, and respiratory syncytial virus (RSV).
The key for NVAX stock is the company's strong pipeline of drug candidates. Its vaccine for the H7N9 virus was fast-tracked by the U.S. Food and Drug Administration. That speeds up the approval process significantly and acts as a catalyst for the stock price.
The company is also working on an RSV vaccine and an Ebola treatment.
Keep an eye out for updates on Novavax's clinical trials. Any positive results could send shares soaring even higher.
|
|
|
Post by Anonymous on Nov 19, 2015 6:24:27 GMT
I've been keeping tab of them and they show signs of weakening so i suggest to sell it when you get small profit and move on
|
|